is compounded semaglutide safe for weight loss Microdose Compounded GLP-1s: A Safe &
Description
Royal Pharm Retatrutide 2381089-83-2 Retatrutide 2381089-83-2 Description API name: Retatrutide CAS No.: 2381089-83-2 Structure: Usage Retatrutide is a triple agonist of GLP-1, GIP, and glucagon receptors, developed for the treatment of obesity and type 2 diabetes
(February 2026)
July 10, 2023
Australian university tested (not overseas COA) 99% purity verified by HPLC and mass spectrometry Same-day dispatch from Sydney Research-grade lyophilised powder For research use only
The Phase 2 data remains the primary quantitative reference
Association of incretin-based therapies with hepatobiliary disorders among patients with type 2 diabetes: a case series from the FDA adverse event reporting system
